|
arGEN-X BV
company
|
Overview
arGEN-X has developed a platform for the discover of in vivo generated human antibody therapeutics.
Financial Information
Areas of Expertise
Technologies involved in:
Human Monoclonal Antibody,
Antibody screening,
add other
Medical focus:
Corporate Information
Products
Therapeutics on the Market
| Product |
Developed By |
2007 Sales ($M) |
2006 Sales ($M) |
2005 Sales ($M) |
Indications / Phase of Development |
Products on the Market
| Product Brand |
Name |
Developed By |
2007 Sales ($M) |
Therapeutics in Development
| Product |
Developed By |
Indications / Phase of Development |
Products in Development
| Product |
Brand Name |
Overview |
